ARCTEvents•businesswire•
Arcturus Therapeutics to Attend Upcoming Investor Conferences
Sentiment:Negative (15)
Summary
SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that the Company will participate in the following investor conferences: Citi’s 2025 Biopharma Back to School Conference (Fireside Chat) Tuesday, September 2, 2025 (11:15 a.m. ET) 2025 Wells Fargo Healthcare Conference (
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 26, 2025 by businesswire